Literature DB >> 9467741

Loss of oral infectivity of tissue cysts of Toxoplasma gondii RH strain to outbred Swiss Webster mice.

O Villard1, E Candolfi, D J Ferguson, L Marcellin, T Kien.   

Abstract

We have developed a method for obtaining cysts of Toxoplasma gondii RH strain. Outbred Swiss Webster mice were infected subcutaneously (s.c.) or intraperitoneally (i.p) with 10(5) tachyzoites and given sulfadiazine 400 mg l-1 + NaHCO3 10 g l-1 in drinking water from day 1 to day 15 post-infection (p.i.). None of the mice infected i.p. survived, compared with 50% of the mice infected s.c. Cysts were detectable in the brain on day 45 p.i., and had ultrastructural features consistent with those of bradyzoites. However, these cysts were incapable of infecting mice via the oral route. In addition, immunofluorescence studies showed the persistence of P36 protein expression, indicating that the conversion to bradyzoites was incomplete.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9467741     DOI: 10.1016/s0020-7519(97)00144-6

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  13 in total

1.  Toxoplasma gondii targets a protein phosphatase 2C to the nuclei of infected host cells.

Authors:  Luke A Gilbert; Sandeep Ravindran; Jay M Turetzky; John C Boothroyd; Peter J Bradley
Journal:  Eukaryot Cell       Date:  2006-11-03

2.  Reduction of Toxoplasma gondii Development Due to Inhibition of Parasite Antioxidant Enzymes by a Dinuclear Iron(III) Compound.

Authors:  J A Portes; T G Souza; T A T dos Santos; L L R da Silva; T P Ribeiro; M D Pereira; A Horn; C Fernandes; R A DaMatta; W de Souza; S H Seabra
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

3.  Expression of herpes simplex virus thymidine kinase in Toxoplasma gondii attenuates tachyzoite virulence in mice.

Authors:  J R Radke; M W White
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

4.  Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.

Authors:  J A Portes; W De Souza
Journal:  Parasitol Res       Date:  2019-11-14       Impact factor: 2.289

5.  Cancer in the parasitic protozoans Trypanosoma brucei and Toxoplasma gondii.

Authors:  Zhao-Rong Lun; De-Hua Lai; Yan-Zi Wen; Ling-Ling Zheng; Ji-Long Shen; Ting-Bo Yang; Wen-Liang Zhou; Liang-Hu Qu; Geoff Hide; Francisco J Ayala
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-20       Impact factor: 11.205

6.  A new iron(III) complex-containing sulfadiazine inhibits the proliferation and induces cystogenesis of Toxoplasma gondii.

Authors:  Juliana de A Portes; Nathália F B Azeredo; Pedro G T Siqueira; Tatiana Guinancio de Souza; Christiane Fernandes; Adolfo Horn; Dalber R S Candela; Wanderley de Souza; Renato A DaMatta; Sérgio H Seabra
Journal:  Parasitol Res       Date:  2018-06-22       Impact factor: 2.289

7.  Partially protective vaccination permits the development of latency in a normally virulent strain of Toxoplasma gondii.

Authors:  G S Yap; T Scharton-Kersten; D J Ferguson; D Howe; Y Suzuki; A Sher
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Immune responses of mice intraduodenally infected with Toxoplasma gondii KI-1 tachyzoites.

Authors:  Eun-Hee Shin; Yeoun Sook Chun; Won-Hee Kim; Jae-Lip Kim; Kyoung-Ho Pyo; Jong-Yil Chai
Journal:  Korean J Parasitol       Date:  2011-06-14       Impact factor: 1.341

9.  Genetic basis for phenotypic differences between different Toxoplasma gondii type I strains.

Authors:  Ninghan Yang; Andrew Farrell; Wendy Niedelman; Mariane Melo; Diana Lu; Lindsay Julien; Gabor T Marth; Marc-Jan Gubbels; Jeroen P J Saeij
Journal:  BMC Genomics       Date:  2013-07-10       Impact factor: 3.969

10.  Brain Tissue Cysts in Infected Mice with RH-Strain of Toxoplasma gondii and Evaluation of BAG1 and SAG1 Genes Expression.

Authors:  Monavar Selseleh; Mh Modarressi; S Shojaee; M Mohebali; Mr Eshraghian; Mina Selseleh; H Keshavarz
Journal:  Iran J Parasitol       Date:  2013-01       Impact factor: 1.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.